Qiming Venture Partners
Qiming invests $10 million in two life science companies
Qiming Venture Partners, the PRC-focused early and growth stage VC company, has invested a total of $10 million in two life science research service companies, Sangon Biotech in Shanghai and Bio Basic Inc. (BBI) in Toronto.
Qiming Ventures leads $18 million round of financing for LanzaTech
Qiming Ventures has led an $18 million Series B round of funding for New Zealand clean tech firm LanzaTech, while Softbank China Venture Capital and two of LanzaTech’s existing investors from its Series A round - US-based Khosla Ventures and K1W1 from...
Qiming launches RMB fund for biomedical investments
Chinese VC firm Qiming Venture Partners has launched an RMB250 million ($36.6 million) fund, focusing particularly on biomedical sector-related investments.
Kleiner, Qiming invest China's Arrail Dental
Kleiner Perkins Caulfield & Byers China and Qiming Ventures have invested $20 million in Arrail Dental, a leading high-end PRC dental services provider, for an undisclosed stake.
Qiming invests China insulin with Gan & Lee
Qiming Venture Partners has committed just over $14.5 million to Gan & Lee Pharmaceutical Co. Ltd., a PRC manufacturer of insulin that claims to have Asia's largest recombinant insulin manufacturing site.
Healthcare: The next China VC horizon?
PRC healthcare VCs take the market’s temperature